CLINICAL_TRIALS
trial_result
· 2022-06-16
Clinical Trial Update: A Study of Gantenerumab in Participants With Mild Alzheimer Disease [Phase 3]
Summary
Phase 3 clinical trial update for gantenerumab in mild Alzheimer's disease completed; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2022-06-16